The Group’s Revenue Hits New HeightsNet profit for 1H2023 increased more than 2.8 times YoYBenefited from the Full Resumption of Normal TravelRevenue Continues to Generate Profit in Future Results Highlights Since the full resumption of normal travel between Hong Kong, Macau and Mainland China, the number of travellers has rebounded significantly, which is favourable for the … Read more
IND builds on previously-published, preliminary evidence of efficacy Filing is supported by robust manufacturing, pre-clinical and clinical data already reviewed by FDA for NRX-101 associated with treatment of bipolar depression RADNOR, Pa., Aug. 30, 2023 /PRNewswire/ – NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”, the “Company”), a clinical-stage biopharmaceutical company, today announced submission an Investigational New … Read more
Enhanced Analytical Capabilities Offer Comprehensive, Customer-Centric Solutions KITCHENER, ON, Aug. 29, 2023 /PRNewswire/ — Labstat Inc., A Certified Group Company, has entered a strategic partnership with Global Laboratory Services, Inc. (GLS), a subsidiary of Universal Leaf Tobacco Company, Inc. This alliance aligns Labstat’s cutting-edge capabilities with GLS’s comprehensive testing services, enabling both companies to offer tobacco … Read more
WEST CHESTER, Pa., Aug. 28, 2023 /PRNewswire/ — In response to a significant global unmet need for the “SUTURE-TIGHT”™ catheter, VESTECK, Inc. is expanding the International Scientific Advisory Board. We are honored to have Professor Dainis Krievins, from Latvia, Canadian, Dr. Bao Bui and Australian, Professor Ramon Varcoe join the VESTECK Scientific Advisory Board. VESTECK … Read more
NEW YORK, Aug. 11, 2023 /PRNewswire/ — The modified starch market size is expected to grow by USD 2,862.71 million during 2022-2027, progressing at a CAGR of 4.36% as per the latest Technavio market research report. North America is estimated to account for 35% of the global market growth during the forecast period. The demand for modified starch in the … Read more
EMERYVILLE, Calif., Aug. 9, 2023 /PRNewswire/ — PhenomeX Inc. (Nasdaq: CELL), the functional cell biology company, today announced that the Company will be reporting financial results for the second quarter 2023 after market on Monday, August 14, 2023. About PhenomeX Inc. PhenomeX is empowering scientists to leverage the full potential of each cell and drive the … Read more
HONG KONG, Germantown, Md. and SUZHOU, China, July 27, 2023 /PRNewswire/ — Sirnaomics Ltd. (the “Company”, Stock Code: 2257.HK, together with its subsidiaries, the “Group” or “Sirnaomics”), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, today announced that Dr. Francois Lebel, M.D., an experienced biopharmaceutical industry executive, has been appointed as Senior Vice President for preclinical and clinical development of the … Read more
Possibilité d’avoir un impact plus large car 70 % des leaders d’opinion clés n’interagissent qu’avec une seule entreprise biopharmaceutique BARCELONE, Espagne, 26 juillet 2023 /PRNewswire/ — Veeva Systems (NYSE: VEEV) a révélé aujourd’hui les résultats de l’impact de la médecine de terrain sur la pratique clinique dans le rapport Veeva Pulse Field Trends. L’analyse montre que l’éducation sur l’état de … Read more
Two posters at AAIC will feature SYNTap®, the only seed amplification assay available to aid the diagnosis of synucleinopathies SAN DIEGO, July 15, 2023 /PRNewswire/ — Amprion, a global leader in the advancement of neurodegenerative disorder diagnosis, will be in attendance at the Alzheimer’s Association International Conference® 2023 (AAIC®) in Amsterdam on July 16-20. AAIC … Read more
GRAND BLANC, Mich., July 14, 2023 /PRNewswire/ — ModuleMD, an industry leader in the EHR SaaS market has been recognized as a High Performer in the EHR category by G2. The latest customer reviews in the G2 Summer 2023 report are 98% to 100% positive. One ModuleMD client noted that the company offers a level of … Read more